Key terms

About RCUS

Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest RCUS news

Today 6:21am ET Analysts Offer Insights on Healthcare Companies: Daré Bioscience (DARE), Mereo Biopharma Group Plc (MREO) and Arcus Biosciences (RCUS) by TipRanks Today 6:20am ET Promising Outlook for Arcus Biosciences Anchored by Strong Clinical Trials and Strategic Market Positioning by TipRanks Apr 28 1:33pm ET Arcus Biosciences price target lowered to $37 from $44 at Citi by TipRanks Apr 12 6:50am ET Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC) and Arcus Biosciences (RCUS) by TipRanks Feb 25 11:29pm ET Evaluating Arcus Biosciences’ Casdatifan Potential and Strategic Position in RCC Treatment Landscape by TipRanks Feb 22 7:11am ET Analysts Offer Insights on Healthcare Companies: Crispr Therapeutics AG (CRSP), Arcus Biosciences (RCUS) and United Therapeutics (UTHR) by TipRanks Feb 22 5:40am ET Analysts Offer Insights on Healthcare Companies: Arcus Biosciences (RCUS), Ionis Pharmaceuticals (IONS) and Icon (ICLR) by TipRanks Feb 22 5:07am ET Barclays Sticks to Its Buy Rating for Arcus Biosciences (RCUS) by TipRanks Feb 21 4:11pm ET Arcus Biosciences reports Q4 EPS ($1.08), consensus ($1.02) by TipRanks Feb 08 6:31am ET Analysts Offer Insights on Healthcare Companies: McKesson (MCK), Arcus Biosciences (RCUS) and Neurocrine (NBIX) by TipRanks Feb 02 11:07am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Feb 01 11:24am ET Biotech Alert: Searches spiking for these stocks today by TipRanks

No recent press releases are available for RCUS

RCUS Financials

1-year income & revenue

Key terms

RCUS Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

RCUS Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

The Marriner S. Eccles Federal Reserve building in Washington, DC, on Thursday, Dec. 28, 2023.
Valerie Plesch/Bloomberg/Getty Images
The Fed announced a big change today. And no, we’re not talking about interest rates
A Dave & Buster's location in the Gateway Center shopping complex in the Brooklyn borough of New York, US, on Saturday, March 30, 2024. Dave & Buster's Entertainment Inc. is scheduled to release earnings figures on April 2. Photographer: Bing Guan/Bloomberg
Bing Guan/Bloomberg/Getty Images
Dave and Buster’s is getting into the betting business
All three major indexes closed out April lower, snapping a five-month streak of gains.
Michael M Santiago/Getty Images
Dow closes 570 points lower, capping losing month for stocks ahead of Fed decision
The Federal Reserve building is seen before the Federal Reserve board is expected to signal plans to raise interest rates in March as it focuses on fighting inflation in Washington, U.S., January 26, 2022.
Joshua Roberts/Reuters/File
When will the Fed begin to cut interest rates? It’s a mystery